Figure Gallery

Expression Pattern Search Results for runx1

(401 figures with expression from 192 publications)

[ Show only figures with images ]
Publication	Data	Fish	Condition	Stage Range	Anatomy
Pereboom et al., 2011	Fig. 5	WT tp53^zdf1/zdf1 tp53^zdf1; nop10^hi2578Tg	standard conditions control	Prim-25	dorsal aorta hematopoietic stem cell
Wan et al., 2011	Fig. 3	WT WT + MO1-kmt2a	standard conditions control	10-13 somites to Prim-25	posterior lateral mesoderm ventral wall of dorsal aorta
Wang et al., 2011	Fig. 3	WT WT + MO1-heg1 WT + MO2-krit1	standard conditions standard conditions control	Prim-25	ventral wall of dorsal aorta
	Fig. 6	WT WT + MO1-klf2a	standard conditions control	Prim-5 to Prim-25	hematopoietic multipotent progenitor cell trunk
	Fig. 7	WT WT + MO1-klf2a WT + MO1-tnnt2a	standard conditions standard conditions control chemical treatment: S-nitroso-N-acetyl-D-penicillamine chemical treatment: S-nitroso-N-acetyl-D-penicillamine	Prim-25	hematopoietic multipotent progenitor cell trunk vasculature
	Fig. 2	WT WT + MO1-tnnt2a	standard conditions control	Prim-5 to Prim-25	dorsal aorta
Zhang et al., 2011	Fig. 1	WT myb^hkz3/hkz3	standard conditions control	Long-pec	whole organism
Bertrand et al., 2010	Fig. 2	la4Tg; zf169Tg	standard conditions	Prim-25	hematopoietic stem cell ventral wall of dorsal aorta
Danilova et al., 2010	Fig. 4	TU u2af1^{hi199Tg/hi199Tg}	standard conditions	Prim-15	hematopoietic stem cell
Huang et al., 2010	Fig. 4	AB AB + MO1-smarcal1	standard conditions standard conditions	Prim-5	whole organism
Sood et al., 2010	Fig. 2	WT WT + MO6-runx1	standard conditions standard conditions	Day 5 to Day 6	whole organism
Burns et al., 2009	Fig. 1	WT	standard conditions	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 5
	Fig. 4	kca3Tg; kca4Tg kca3Tg; kca4Tg + MO3-plcg1 kca3Tg; kca4Tg + MO4-tbx16	heat shock heat shock heat shock	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. S1	WT	standard conditions	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
Jin et al., 2009	Fig. 6	gata1a^m651/m651 gata1a^m651/m651 + MO1-tnnt2a	standard conditions control	Prim-15	ventral wall of dorsal aorta hematopoietic multipotent progenitor cell
Kitaguchi et al., 2009	Fig. 6	WT gata1a^m651/m651 WT + MO1-klf17 gata1a^m651/m651 + MO1-klf17	standard conditions standard conditions	Prim-5	intermediate cell mass of mesoderm myeloid cell
	Fig. 3	WT WT + MO1-spi1b WT + MO3-cebp1	standard conditions standard conditions standard conditions	Prim-5	intermediate cell mass of mesoderm myeloid cell Rohon-Beard neuron
Lam et al., 2009	Fig. 3	WT WT + MO7-runx1 WT + MO9-runx1	standard conditions standard conditions standard conditions	14-19 somites	intermediate cell mass of mesoderm
	Fig. 1	WT	standard conditions	1-cell to Days 21-29	whole organism
	Fig. 6	WT	standard conditions	Days 30-44 to Adult	blood cell
North et al., 2009	Fig. 2	WT tnnt2a^{unspecified/unspecified}	standard conditions	Prim-25	ventral wall of dorsal aorta whole organism
	Fig. 4	WT tnnt2a^{unspecified/unspecified}	control chemical treatment: S-nitroso-N-acetyl-D-penicillamine	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 5	WT WT + MO1-nos1 WT + MO1-nos2a WT + MO2-nos1 WT + MO2-nos2a	standard conditions standard conditions standard conditions standard conditions control chemical treatment: N-[3-(aminomethyl)benzyl]acetamidine chemical treatment: pharmaceutical chemical treatment: S-methyl-L-thiocitrulline	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell
	Fig. 1	WT	control chemical treatment: pharmaceutical chemical treatment: S-nitroso-N-acetyl-D-penicillamine	Prim-25	ventral wall of dorsal aorta hematopoietic stem cell